Literature DB >> 14999783

Explaining gastric cancer survival differences among European countries.

Arduino Verdecchia1, Isabella Corazziari, Gemma Gatta, Daniele Lisi, Jean Faivre, David Forman.   

Abstract

Wide geographic variability in incidence and mortality rates for gastric cancer exists throughout the world despite persistent decreases over several decades. Variability in survival from gastric cancer is also evident and countries with higher incidence rates of gastric cancer show better survival rates than countries with lower incidence. The aim of this study was to identify reasons for the association between incidence and survival and to obtain survival estimates and differences corrected for this variation, thus facilitating further interpretation by clinical factors such as stage and treatment. Relative survival rates for gastric cancer derived from the EUROCARE-2 database for 47 cancer registries in 17 European countries were analyzed with regression methods to adjust differences by age, sex, period of diagnosis, subsite of the stomach, histologic type and stage at diagnosis. Overall, nearly 60% of the variability in gastric cancer relative survival was explained by differences in these variables. Factors are related to treatment and general management of patients is expected to explain the residual variability in gastric cancer survival between European countries. There is a need to improve completeness and standardization of detailed information collected on gastric cancer patients to allow detailed comparative analyses and interpretation. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 14999783     DOI: 10.1002/ijc.20047

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  30 in total

1.  MicroRNA-204-5p inhibits gastric cancer cell proliferation by downregulating USP47 and RAB22A.

Authors:  Binbin Zhang; Yuan Yin; Yaling Hu; Jiwei Zhang; Zehua Bian; Mingxu Song; Dong Hua; Zhaohui Huang
Journal:  Med Oncol       Date:  2014-11-28       Impact factor: 3.064

2.  Ethnicity-related differences in tumor immunity: a new possible explanation for gastric cancer prognostic variability?

Authors:  Daniele Marrelli; Karol Polom; Franco Roviello
Journal:  Transl Gastroenterol Hepatol       Date:  2016-03-16

Review 3.  Multimodal treatment of gastric cancer in the west: Where are we going?

Authors:  Daniele Marrelli; Karol Polom; Giovanni de Manzoni; Paolo Morgagni; Gian Luca Baiocchi; Franco Roviello
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

Review 4.  MicroRNAs in gastric cancer: from benchtop to bedside.

Authors:  Fuyi Tong; Peng Cao; Yuan Yin; Suhua Xia; Rensheng Lai; Shenlin Liu
Journal:  Dig Dis Sci       Date:  2013-10-10       Impact factor: 3.199

5.  Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: Results from EUROCARE-5.

Authors:  L A Anderson; A Tavilla; H Brenner; S Luttmann; C Navarro; A T Gavin; B Holleczek; B T Johnston; M B Cook; F Bannon; M Sant
Journal:  Eur J Cancer       Date:  2015-09-26       Impact factor: 9.162

6.  Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma.

Authors:  Zheng Chen; Rama Saad; Peilin Jia; DunFa Peng; Shoumin Zhu; M Kay Washington; Zhongming Zhao; Zekuan Xu; Wael El-Rifai
Journal:  Cancer       Date:  2013-03-01       Impact factor: 6.860

7.  An orthotopic nude mouse model for preclinical research of gastric cardia cancer.

Authors:  Sarah Bhargava; Birgit Hotz; Heinz J Buhr; Hubert G Hotz
Journal:  Int J Colorectal Dis       Date:  2008-09-30       Impact factor: 2.571

Review 8.  Clinical application of microRNA in gastric cancer in Eastern Asian area.

Authors:  Ming Gao; Hao Yin; Zhe-Wei Fei
Journal:  World J Gastroenterol       Date:  2013-04-07       Impact factor: 5.742

9.  High-risk and low-risk gastric cancer areas in Italy and its association with microsatellite instability.

Authors:  Karol Polom; Daniele Marrelli; Valeria Pascale; Giandomenico Roviello; Costantino Voglino; Henry Rho; Carla Vindigni; Mario Marini; Raffaele Macchiarelli; Franco Roviello
Journal:  J Cancer Res Clin Oncol       Date:  2016-05-20       Impact factor: 4.553

Review 10.  Epidemiology of gastric cancer.

Authors:  Katherine D Crew; Alfred I Neugut
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.